Jonathan McNeill, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 60,300 shares at $11.57 ($698K) on 2023-01-09, disclosed to the SEC on 2023-01-11.
Open-market sale of $698k DYN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.57 | 30,150 | $349K | 50.0% |
| 2 | $11.57 | 30,150 | $349K | 50.0% |
| Total | $11.57 avg | 60,300 | $698K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |